Adipose-derived mesenchymal cell derivation, characterization and differentiation for potential use in cell replacement therapy for diabetes
Loading...
Download
Associated Records
Authors
File Licence
Editors
Date
2013
Source Title
Journal Title
Journal ISSN
Volume Title
Publisher
Melbourne Authors
Affiliation
Department of Surgery (St Vincent's), Faculty of Medicine, Dentistry & Health Sciences
Document Type
PhD thesis
Subject Code
Citation
Williams, M. D. (2013). Adipose-derived mesenchymal cell derivation, characterization and differentiation for potential use in cell replacement therapy for diabetes. PhD thesis, Department of Surgery (St Vincent’s Hospital), The University of Melbourne.
Access Status
This item is currently not available from this repository
Access URL
Open Access URL
Open Access at PMC
Linked Resource URL
NHMRC Grant Code
ARC Grant Code
Description
© 2013 Dr. Michael David Williams
Publications included in thesis:
Williams, M. D., & Mitchell, G. M. (2012). MicroRnAs in insulin resistance and obesity. Experimental Diabetes Research, 2012, 291-298. DOI: 10.1155/2012/484696
Satoor, S. N., Puranik, A. S., Kumar, S., Williams, M. D., Ghale, M., Rahalkar, A., et al. (2011). Location, location, location: beneficial effects of autologous fat transplantation. Scientific Reports, 1(81). DOI: 10.1038/srep00081
Williams, M. D., Mitchell, G. M., & Hardikar, A. A. (2011). Stem cells: epigenetic basis of differentiation. Open Stem Cell Journal 3, 28-33.
Publications included in thesis:
Williams, M. D., & Mitchell, G. M. (2012). MicroRnAs in insulin resistance and obesity. Experimental Diabetes Research, 2012, 291-298. DOI: 10.1155/2012/484696
Satoor, S. N., Puranik, A. S., Kumar, S., Williams, M. D., Ghale, M., Rahalkar, A., et al. (2011). Location, location, location: beneficial effects of autologous fat transplantation. Scientific Reports, 1(81). DOI: 10.1038/srep00081
Williams, M. D., Mitchell, G. M., & Hardikar, A. A. (2011). Stem cells: epigenetic basis of differentiation. Open Stem Cell Journal 3, 28-33.
Abstract
Type 1 diabetes (T1D) is characterized by the loss of insulin-producing β-cells in the pancreas. T1D can be treated using cadaveric islet transplantation, but this therapy is severely limited by a lack of donor pancreas. To develop an alternative cell therapy, candidate populations were identified through epigenetic characterization of multiple tissues. Histone modification status at the promoter region of key endocrine pancreatic genes was assessed using chromatin immunoprecipitation sequencing (ChIP-seq) and validated using promoter-specific TaqMan-based quantitative PCR (qPCR). Visceral fat was identified as a tissue retaining epigenetic signatures similar to those observed in the pancreas. Human adipose-derived mesenchymal cells (AMCs) were characterized using flowcytometry, confocal microscopy, qPCR, in situ PCR and next generation sequencing technologies. Multiple transcription factor-encoding adenoviruses (e.g. Pdx1, MafA, Ngn3) were employed to determine the differentiation potential of these cells. Analysis of multiple pancreatic hormones and transcription factors in these samples demonstrated consistent differentiation. The differentiation potential was further explored using AMCs isolated from transgenic mice that express GFP under the regulation of Pdx1 (pancreatic and duodenal homeobox 1) or insulin-1 gene promoters. GFP expression was quantitated as an index of gene promoter activity during differentiation to insulin-producing cells, in the presence of various pro-differentiation small molecules.
Human AMCs were exposed to a standard differentiation protocol and seen to migrate to form islet-like cell aggregates (ICAs), showing significant increases in islet hormone transcripts in vitro. These adipose-derived ICAs were transplanted into immunocompromised animals using two models of transplantation. Cells were transplanted in a Theracyte immunoisolation device into the peritoneum, and within a blood clot under the kidney capsule. Transplanted cells maintained expression of endocrine pancreatic transcription factors and did not undergo a regressive mesenchymal transition following surgery. Circulating blood samples collected from peripheral circulation of these mice, following a glucose injection, showed that differentiated and engrafted human AMCs could sense, transcribe, translate, package and secrete insulin in response to a glucose stimulus. These studies indicate that human AMCs can differentiate into insulin-producing cells in vitro and have potential for cell replacement therapy in diabetes.
Notes
Terms of Use
Keywords
epigenetics, progentior cell, cell differentiation, adipose, diabetes, obesity, endocrinology